Paired with Roche's HPV testing offerings, the deal will expand its cervical cancer testing capabilities.
The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.
The funds will be used to support clinical trials and commercialization efforts, as well as US regulatory clinical trials for a PMA submission for its CINtec Plus Cytology platform.
The CTAF recommendation is "an important decision-making resource for clinicians and patients," the firm's CEO said.
Patents awarded to GeneNews, US Army, Aisin Seiki, MTM Laboratories, and USC.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.